Michael Krams

Plus aucun poste en cours

65 ans

Health Technology

Consumer Services

Technology Services

Profil

Michael Krams worked as the Vice President-Adaptive Trials at Wyeth LLC.
He then served as the Head-Quantitative Sciences at Janssen Pharmaceuticals, Inc. from 2013 to 2022.
Currently, he is the Chief Quantitative Medicine Officer at Exscientia Plc.
Dr. Krams holds a doctorate degree from Ludwig-Maximilians-Universität München.

Anciens postes connus de Michael Krams

Sociétés	Poste	Fin
EXSCIENTIA PLC	Directeur Technique/Scientifique/R&D	06/06/2024
Janssen Pharmaceuticals, Inc. Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs	Corporate Officer/Principal	01/02/2022
Wyeth Corp. Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products	Corporate Officer/Principal	-

Voir l'expérience en détail de Michael Krams

Formation de Michael Krams

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Michael Krams

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	4
Wyeth Corp. Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products	Health Technology
Janssen Pharmaceuticals, Inc. Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs	Health Technology
Ludwig-Maximilians-Universität München Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Exscientia Plc Exscientia Plc Packaged SoftwareTechnology Services Function as an investment holding company whose subsidiaries provides artificial intelligence and machine learning services	Technology Services